Clarithromycin Supplier-Buyer Network — Trade Flow Analysis

Name: Clarithromycin Supplier-Buyer Trade Network Dataset — 334+ Indian Exporters, 24+ Importers, 144+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Clarithromycin supplier network, Clarithromycin buyers, pharmaceutical export India, Clarithromycin trade data

TransData Nexus

Clarithromycin

India Pharmaceutical Trade Intelligence

$98.4M334 Suppliers144 CountriesHS 30042063

ExportsIndia → UNITED KINGDOM18.6%India → BELGIUM11.6%

ImportsUNITED STATES → India$112.9K ROMANIA → India$7.6K

#1 Supplier: MICRO LABS #1 Buyer: BROWN AND

Who Supplies Clarithromycin? Top Manufacturers & Buyers 2026 — MICRO LABS LIMITED Leads | TransData Nexus | TransData Nexus

1MICRO LABS LIMITED

MICRO LABS LIMITED is the first-largest Clarithromycin exporter from India, with a market share of 15.4% and a total export value of $15.2M across 308 shipments. Their average shipment value of $49.3K is above the market average of $27.5K, suggesting premium or bulk contract pricing.

MICRO LABS LIMITED serves 5 named buyers in our database. BROWN AND BURK LIMITED is the dominant customer, accounting for 74.5% of this supplier's tracked business. Top customers include:

• BROWN AND BURK LIMITED — $11.3M across 229 shipments (74.5% of this supplier's total exports)

• BROWN AND BURK UK LIMITED — $2.0M across 41 shipments (13.3% of this supplier's total exports)

• JSC AKRIKHIN — $833.3K across 17 shipments (5.5% of this supplier's total exports)

• HATAY PHARMACEUTICAL — $551.4K across 11 shipments (3.6% of this supplier's total exports)

• LABOREX UGANDA LIMIT — $467.0K across 9 shipments (3.1% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED's per-shipment value of $49.3K is 79% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Clarithromycin exporter from India, with a market share of 11.7% and a total export value of $11.5M across 309 shipments. Their average shipment value of $37.2K is above the market average of $27.5K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN is the dominant customer, accounting for 74.4% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $8.5M across 230 shipments (74.4% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.2M across 31 shipments (10.0% of this supplier's total exports)

• M/S. YUSEN LOGISTICS — $737.8K across 20 shipments (6.4% of this supplier's total exports)

• LLC RANBAXY PHARMACE — $547.9K across 15 shipments (4.8% of this supplier's total exports)

• AO RANBAXY — $511.2K across 14 shipments (4.4% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $37.2K is 35% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Clarithromycin exporter from India, with a market share of 4.7% and a total export value of $4.6M across 43 shipments. Their average shipment value of $106.8K is above the market average of $27.5K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. CIPLA KENYA LTD C/O IMPERIAL MANAGE is the dominant customer, accounting for 70.4% of this supplier's tracked business. Top customers include:

• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $3.2M across 30 shipments (70.4% of this supplier's total exports)

• ABACUS PHARMA LTD — $839.1K across 8 shipments (18.3% of this supplier's total exports)

• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $241.3K across 2 shipments (5.3% of this supplier's total exports)

• HIGEN COMPANY — $164.2K across 2 shipments (3.6% of this supplier's total exports)

• ABACUS PHARMA LIMITE — $117.4K across 1 shipments (2.6% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $106.8K is 288% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.

4WEXFORD LABORATORIES PRIVATE LIMITED

WEXFORD LABORATORIES PRIVATE LIMITED is the fourth-largest Clarithromycin exporter from India, with a market share of 3.9% and a total export value of $3.9M across 35 shipments. Their average shipment value of $110.1K is above the market average of $27.5K, suggesting premium or bulk contract pricing.

WEXFORD LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. DYVENPRO DISTRIBUCION Y VENTA DE is the dominant customer, accounting for 96.3% of this supplier's tracked business. Top customers include:

• DYVENPRO DISTRIBUCION Y VENTA DE — $3.7M across 34 shipments (96.3% of this supplier's total exports)

• DROGUERIA AMERICANA — $44.6K across 0 shipments (1.2% of this supplier's total exports)

• LABORATORIOS FARSIMA — $40.1K across 0 shipments (1.0% of this supplier's total exports)

• DROGUERIA AMERICANA — $37.0K across 0 shipments (1.0% of this supplier's total exports)

• LABORATORIOS FARSIMA — $19.1K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: WEXFORD LABORATORIES PRIVATE LIMITED's per-shipment value of $110.1K is 300% above the market average of $27.5K, consistent with large-order contracts or value-added formulations.

5AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Clarithromycin exporter from India, with a market share of 3.7% and a total export value of $3.6M across 183 shipments. Their average shipment value of $19.9K is below the market average of $27.5K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.5M across 77 shipments (42.0% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. — $631.3K across 32 shipments (17.3% of this supplier's total exports)

• MILPHARM LIMITED — $589.7K across 30 shipments (16.2% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. — $555.1K across 28 shipments (15.2% of this supplier's total exports)

• APL SWIFT SERVICES ( — $335.1K across 17 shipments (9.2% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (183 shipments) at a per-shipment value of $19.9K, indicating a broad distribution network with many smaller, regular orders.

6CAPLIN POINT LABORATORIES LIMITED

CAPLIN POINT LABORATORIES LIMITED is the fifth-largest Clarithromycin exporter from India, with a market share of 2.4% and a total export value of $2.3M across 110 shipments. Their average shipment value of $21.2K is below the market average of $27.5K, reflecting a high-volume, competitive pricing strategy.

CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DROGUERIA SAIMED S A — $614.3K across 29 shipments (26.4% of this supplier's total exports)

• DROGUERIA SAIMED S A — $571.1K across 27 shipments (24.5% of this supplier's total exports)

• SALDENT INTERNACIONA — $482.2K across 23 shipments (20.7% of this supplier's total exports)

• CAPLIN POINT COSTA R — $412.8K across 19 shipments (17.7% of this supplier's total exports)

• VITAFARMA S.A. — $248.9K across 12 shipments (10.7% of this supplier's total exports)

Key Insight: CAPLIN POINT LABORATORIES LIMITED operates with high shipment frequency (110 shipments) at a per-shipment value of $21.2K, indicating a broad distribution network with many smaller, regular orders.

1United Kingdom

United Kingdom ranks as the first-largest destination for Clarithromycin imports from India, with a total trade value of $18.3M across 88 shipments — representing a 18.6% share of all Clarithromycin exports. The average shipment value of $207.9K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Clarithromycin importers in United Kingdom: BROWN AND BURK LIMITED is the largest buyer, accounting for 63.0% ($11.5M) of this market's total imports.

• BROWN AND BURK LIMITED — $11.5M (63.0% of United Kingdom's total)

• BROWN AND BURK UK LIMITED — $2.1M (11.7% of United Kingdom's total)

• MEDLEY PHARMA LTD — $1.1M (6.2% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $207.9K (656% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Clarithromycin imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Clarithromycin imports from India, with a total trade value of $11.4M across 213 shipments — representing a 11.6% share of all Clarithromycin exports. The average shipment value of $53.4K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Clarithromycin importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 80.8% ($9.2M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $9.2M (80.8% of Belgium's total)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.3M (11.5% of Belgium's total)

Key Insight: Belgium's per-shipment average of $53.4K (94% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Clarithromycin imports from India.

Primary Market

Secondary Market

3Tanzania

Tanzania ranks as the third-largest destination for Clarithromycin imports from India, with a total trade value of $8.4M across 28 shipments — representing a 8.5% share of all Clarithromycin exports. The average shipment value of $299.6K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Clarithromycin importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 46.4% ($3.9M) of this market's total imports.

• HEKO PHARMACY LTD — $3.9M (46.4% of Tanzania's total)

• ASTRA PHARMA (T) LTD — $3.2M (38.4% of Tanzania's total)

Key Insight: Tanzania's per-shipment average of $299.6K (989% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tanzania is a key market for Clarithromycin imports from India.

Primary Market

Secondary Market

4United States

United States ranks as the fourth-largest destination for Clarithromycin imports from India, with a total trade value of $8.3M across 45 shipments — representing a 8.5% share of all Clarithromycin exports. The average shipment value of $185.5K is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Clarithromycin importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 19.2% ($1.6M) of this market's total imports.

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.6M (19.2% of United States's total)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.6M (18.8% of United States's total)

• RISING PHARMA HOLDINGS INC — $1.3M (16.0% of United States's total)

Key Insight: United States's per-shipment average of $185.5K (574% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Clarithromycin imports from India.

Primary Market

Secondary Market

5Kenya

Kenya ranks as the fifth-largest destination for Clarithromycin imports from India, with a total trade value of $5.8M across 2 shipments — representing a 5.9% share of all Clarithromycin exports. The average shipment value of $2.9M is above the global average of $27.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Clarithromycin importers in Kenya: CIPLA KENYA LTD C/O IMPERIAL MANAGE is the largest buyer, accounting for 55.9% ($3.2M) of this market's total imports.

• CIPLA KENYA LTD C/O IMPERIAL MANAGE — $3.2M (55.9% of Kenya's total)

Key Insight: Kenya's per-shipment average of $2.9M (10411% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Clarithromycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Clarithromycin.
2.Flow Mapping: 334 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,576 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 144 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,576 Verified Shipments

334 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Clarithromycin

Clarithromycin

Who Supplies Clarithromycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Clarithromycin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Clarithromycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Clarithromycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MICRO LABS LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

3CIPLA LIMITED

4WEXFORD LABORATORIES PRIVATE LIMITED

5AUROBINDO PHARMA LTD

6CAPLIN POINT LABORATORIES LIMITED

From Indian Factories to Global Pharmacies — How Clarithromycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Clarithromycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

2Belgium

3Tanzania

4United States

5Kenya

People Also Ask — Clarithromycin Supplier & Trade Network

Clarithromycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology